제품 수집
제품 세부정보
Source
Monoclonal Anti-Her2 Antibody, Human IgG1 is a recombinant chimeric monoclonal antibody expressed in HEK293, which combines the variable region of a mouse monoclonal antibody with human constant domain.
Antibody Type
Recombinant Monoclonal
Isotype
Human IgG1, Kappa
Host Species
Mouse
Reactivity
Human
Specificity
This product is a specific antibody against Her2.
Application
ApplicationRecommended UsageELISA0.2-2 μg/mLPurification
Protein A purified / Protein G purified.
Concentration
Please refer to the Certificate of Analysis (CoA).
Form
Liquid
Formulation
Supplied a 0.22 μm-filtered solution in pH 6.0, 20 mM L-Histidine, with trehalose as protectant.
Please contact us for customized product forms or formulations.
Storage
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- The product MUST be stored at -70°C or lower upon receipt;
- -70°C for 12 months under sterile conditions.
Notices
Product Specific Notices: For research use only.
ACRO Quality Management System
고객님도 확인한 상품
데이터 표시
Bioactivity-ELISA
Immobilized Human Her2, His Tag (Cat. No. HE2-H5225) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Her2 Antibody, Human IgG1 (Cat. No. HE2-M598) with a linear range of 0.06-2 ng/mL (QC tested).
Protocol
Immobilized Human Her2 (498-648), His Tag (Cat. No. HE2-H52H4) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Her2 Antibody, Human IgG1 (Cat. No. HE2-M598) with a linear range of 0.06-2 ng/mL (Routinely tested).
Protocol
Immobilized Human Her2 (S310F), His Tag (Cat. No. HE2-H52H2) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Her2 Antibody, Human IgG1 (Cat. No. HE2-M598) with a linear range of 0.06-2 ng/mL (Routinely tested).
Protocol
Immobilized Human Her2 (S310Y), His Tag (Cat. No. HE2-H52H3) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Her2 Antibody, Human IgG1 (Cat. No. HE2-M598) with a linear range of 0.06-2 ng/mL (Routinely tested).
Protocol
사용자 리뷰 댓글 남기기
배경 소개
프론티어 진행
의약품 개발 진행- 영어 이름：
Receptor protein-tyrosine kinase erbB-2
- 카테고리：
- 상장 의약품 수：
47 상세
- 임상 의약품 수：
238 상세
- 최고 개발 단계：
Approved
연락하기
전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
신약 후보물질 라이선싱
